Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LNPEP | Q9UIQ6 | 6/20 | 0.55 |
| ▸ | ANPEP | P15144 | 3/20 | 0.49 |
| ▸ | XIAP | P98170 | 1/20 | 0.49 |
| ▸ | REN | P00797 | 4/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.43 |
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30426901 | 0.87 | REN (0.50) | LNPEPANPEPRENNTSR2NTSR1 | |
| SCHEMBL30262170 | 0.86 | F2 (0.56) | RENAGTR1AGTR2NTSR2NTSR1 | |
| SCHEMBL29630789 | 0.85 | DPP3 (0.46) | LNPEPANPEPXIAPRENDPP3 | |
| SCHEMBL29649750 | 0.85 | XIAP (0.56) | LNPEPANPEPXIAPRENNTSR2 | |
| Angiotensin Iv SCHEMBL4322224 | 0.84 | LNPEP (0.68) | LNPEPANPEPRENAGTR1AGTR2 | |
| Angiotensin Iv SCHEMBL4322236 | 0.84 | LNPEP (0.68) | LNPEPANPEPRENAGTR1AGTR2 | |
| SCHEMBL11782844 | 0.84 | LNPEP (0.64) | LNPEPANPEPXIAPRENNTSR2 | |
| SCHEMBL11782852 | 0.84 | LNPEP (0.64) | LNPEPANPEPXIAPRENNTSR2 | |
| SCHEMBL11038285 | 0.83 | XIAP (0.45) | LNPEPANPEPXIAPREN | |
| SCHEMBL29589034 | 0.83 | TRHR (0.48) | LNPEPDPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240352445-A1 | HUMANIZATION, AFFINITY MATURATION, AND OPTIMIZATION METHODS FOR PROTEINS AND ANTIBODIES | ABWIZ BIO, INC. | 2024-10-24 | — | — | US | disclosed |